Literature DB >> 29240543

STOMPing Out Hormone-Sensitive Metastases With Local Therapies in Prostate Cancer.

Ryan M Phillips1, Jonathan Hayman1, Phuoc T Tran1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 29240543      PMCID: PMC9250283          DOI: 10.1200/JCO.2017.76.5495

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   50.717


× No keyword cloud information.
  29 in total

1.  Spatial genomic heterogeneity within localized, multifocal prostate cancer.

Authors:  Paul C Boutros; Michael Fraser; Nicholas J Harding; Richard de Borja; Dominique Trudel; Emilie Lalonde; Alice Meng; Pablo H Hennings-Yeomans; Andrew McPherson; Veronica Y Sabelnykova; Amin Zia; Natalie S Fox; Julie Livingstone; Yu-Jia Shiah; Jianxin Wang; Timothy A Beck; Cherry L Have; Taryne Chong; Michelle Sam; Jeremy Johns; Lee Timms; Nicholas Buchner; Ada Wong; John D Watson; Trent T Simmons; Christine P'ng; Gaetano Zafarana; Francis Nguyen; Xuemei Luo; Kenneth C Chu; Stephenie D Prokopec; Jenna Sykes; Alan Dal Pra; Alejandro Berlin; Andrew Brown; Michelle A Chan-Seng-Yue; Fouad Yousif; Robert E Denroche; Lauren C Chong; Gregory M Chen; Esther Jung; Clement Fung; Maud H W Starmans; Hanbo Chen; Shaylan K Govind; James Hawley; Alister D'Costa; Melania Pintilie; Daryl Waggott; Faraz Hach; Philippe Lambin; Lakshmi B Muthuswamy; Colin Cooper; Rosalind Eeles; David Neal; Bernard Tetu; Cenk Sahinalp; Lincoln D Stein; Neil Fleshner; Sohrab P Shah; Colin C Collins; Thomas J Hudson; John D McPherson; Theodorus van der Kwast; Robert G Bristow
Journal:  Nat Genet       Date:  2015-05-25       Impact factor: 38.330

2.  Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan.

Authors:  M S Soloway; S W Hardeman; D Hickey; J Raymond; B Todd; S Soloway; M Moinuddin
Journal:  Cancer       Date:  1988-01-01       Impact factor: 6.860

3.  Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer.

Authors:  Alexander Muacevic; Markus Kufeld; Carsten Rist; Berndt Wowra; Christian Stief; Michael Staehler
Journal:  Urol Oncol       Date:  2011-04-11       Impact factor: 3.498

4.  TWIST1-WDR5-Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis.

Authors:  Reem Malek; Rajendra P Gajula; Russell D Williams; Belinda Nghiem; Brian W Simons; Katriana Nugent; Hailun Wang; Kekoa Taparra; Ghali Lemtiri-Chlieh; Arum R Yoon; Lawrence True; Steven S An; Theodore L DeWeese; Ashley E Ross; Edward M Schaeffer; Kenneth J Pienta; Paula J Hurley; Colm Morrissey; Phuoc T Tran
Journal:  Cancer Res       Date:  2017-05-08       Impact factor: 12.701

5.  "Gotta Catch 'em All", or Do We? Pokemet Approach to Metastatic Prostate Cancer.

Authors:  Declan G Murphy; Christopher J Sweeney; Bertrand Tombal
Journal:  Eur Urol       Date:  2017-03-07       Impact factor: 20.096

6.  Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial.

Authors:  Swetha Sridharan; Allison Steigler; Nigel A Spry; David Joseph; David S Lamb; John H Matthews; Chris Atkinson; Keen-Hun Tai; Gillian Duchesne; David Christie; John Attia; Elizabeth G Holliday; James W Denham
Journal:  Radiother Oncol       Date:  2016-08-12       Impact factor: 6.280

7.  14q32-encoded microRNAs mediate an oligometastatic phenotype.

Authors:  Abhineet Uppal; Sean C Wightman; Stephen Mallon; Go Oshima; Sean P Pitroda; Qingbei Zhang; Xiaona Huang; Thomas E Darga; Lei Huang; Jorge Andrade; Huiping Liu; Mark K Ferguson; Geoffrey L Greene; Mitchell C Posner; Samuel Hellman; Nikolai N Khodarev; Ralph R Weichselbaum
Journal:  Oncotarget       Date:  2015-02-28

8.  Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence.

Authors:  Karel Decaestecker; Gert De Meerleer; Bieke Lambert; Louke Delrue; Valérie Fonteyne; Tom Claeys; Filip De Vos; Wouter Huysse; Arne Hautekiet; Gaethan Maes; Piet Ost
Journal:  Radiat Oncol       Date:  2014-06-12       Impact factor: 3.481

9.  Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.

Authors:  Daniel R Gomez; George R Blumenschein; J Jack Lee; Mike Hernandez; Rong Ye; D Ross Camidge; Robert C Doebele; Ferdinandos Skoulidis; Laurie E Gaspar; Don L Gibbons; Jose A Karam; Brian D Kavanagh; Chad Tang; Ritsuko Komaki; Alexander V Louie; David A Palma; Anne S Tsao; Boris Sepesi; William N William; Jianjun Zhang; Qiuling Shi; Xin Shelley Wang; Stephen G Swisher; John V Heymach
Journal:  Lancet Oncol       Date:  2016-10-24       Impact factor: 41.316

10.  Altering the Natural History of Oligometastatic Prostate Cancer With Local Therapies: Reality Versus Illusion.

Authors:  Phuoc T Tran; Emmanuel S Antonarakis
Journal:  J Oncol Pract       Date:  2017-01-03       Impact factor: 3.840

View more
  3 in total

1.  Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment.

Authors:  C Leigh Moyer; Ryan Phillips; Matthew P Deek; Noura Radwan; Ashley E Ross; Emmanuel S Antonarakis; Diane Reyes; Jean Wright; Stephanie A Terezakis; Daniel Y Song; Curtiland DeVille; Patrick C Walsh; Theodore L DeWeese; Michael Carducci; Edward M Schaeffer; Kenneth J Pienta; Mario Eisenberger; Phuoc T Tran
Journal:  World J Urol       Date:  2018-09-06       Impact factor: 4.226

Review 2.  Oligometastatic prostate cancer: Reality or figment of imagination?

Authors:  Corey C Foster; Ralph R Weichselbaum; Sean P Pitroda
Journal:  Cancer       Date:  2018-12-06       Impact factor: 6.860

3.  A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS).

Authors:  Hamza Hasan; Matthew P Deek; Ryan Phillips; Robert F Hobbs; Reem Malek; Noura Radwan; Ana P Kiess; Shirl Dipasquale; James Huang; Terry Caldwell; Jessica Leitzel; Danielle Wendler; Hao Wang; Elizabeth Thompson; Jonathan Powell; Sara Dudley; Curtiland Deville; Stephen C Greco; Daniel Y Song; Theodore L DeWeese; Michael A Gorin; Steven P Rowe; Sam Denmeade; Mark Markowski; Emmanuel S Antonarakis; Michael A Carducci; Mario A Eisenberger; Martin G Pomper; Kenneth J Pienta; Channing J Paller; Phuoc T Tran
Journal:  BMC Cancer       Date:  2020-06-01       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.